Three reasons the drug industry should be worried about Biden’s HHS pick, Xavier Becerra

Stat News

8 December 2020 -  For a pharmaceutical industry that has spent two years sparring with health secretary Alex Azar, a former Eli Lilly executive fixated on the issue of high drug prices, President-elect Biden’s pick for the role, Xavier Becerra, may seem like incredible news. 

In his health policy work, Becerra has focused far more on Obamacare and health disparities than on the high price of medicines.

Read Stat News article

Michael Wonder

Posted by:

Michael Wonder